ARCHIVES

Alan Rabson Named Acting NCI Director

This article is from The Cancer Letter archive.

Vol. 27 No. 36 | October 5, 2001

Download PDF Visit The Full Archive

Related Articles

RFA On etiology Of AIDS, Kaposi’s

June 3, 1983

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

January 7, 2005

Advances In Cancer Control Meeting Is Set For March 22

February 3, 1989

DCBD Board Approves Recompetition Concepts, Including Cell Banks, Contrast Agents, Hepatoma Resources

November 14, 1980

DCPC Advisors Okay Continuation of Children’s Diet Study

January 31, 1992

Funding Opportunities (8-page issue).

April 25, 2003